The weight loss drug conversation has been accelerating for years – from the early Ozempic headlines through the Wegovy wave ...

Retatrutide is the latest compound to emerge from the revolution in hormonal treatment begun with the introduction of ...

Eli Lilly is just wrapping up trials of its retatrutide, but consumers already are flocking to black-market versions. Can Lilly compete with copies of its own drug?

Retatrutide is still experimental. It hasn’t been approved for use anywhere in the world, yet it’s already circulating through illicit online markets. Retatrutide, often shortened to “reta”, is a ...

The world is full of overweight and obese people who find it impossible to lose weight by diet and exercise alone. Many of them are desperate to find a weight management product that can help them ...

Retatrutide, Eli Lilly’s next obesity shot, showed far more weight loss in clinical trial patients than other blockbuster ...

The latest clinical trial results for retatrutide suggest this experimental drug could help adults with obesity shed more ...

Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

Julian Becerra first learned about retatrutide while scrolling social media. The 24-year-old saw Dawson Weiss, a bodybuilder, post unbelievable photos on TikTok — his muscles rippling, his torso ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." By now, your news feed, your dinner table conversations, and your doctor’s office have been flooded with ...

Retatrutide (LY-3437943) is a new drug being developed by Eli Lilly and Co. It’s intended to be used for treating type 2 diabetes and obesity and is presently undergoing Phase 2 clinical trials. As is ...